Mary J. Laughlin | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Mary J. Laughlin is active.

Explore More

Publication

Featured researches published by Mary J. Laughlin.

Biology of Blood and Marrow Transplantation | 2005

High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: An effective regimen with low morbidity and mortality

Punit D. Wadhwa; Pingfu Fu; Omer N. Koc; Brenda W. Cooper; Robert M. Fox; Richard J. Creger; David L. Bajor; Teja Bedi; Mary J. Laughlin; Jennifer Payne; Stanton L. Gerson; Hillard M. Lazarus

Leukemia Research | 2003

Hematopoietic recovery after unrelated umbilical cord-blood allogeneic transplantation in adults treated with in vivo stem cell factor (R-MetHuSCF) and filgrastim administration

Punit D. Wadhwa; Hillard M. Lazarus; Omer N. Koc; Jennifer Jaroscak; David Woo; Cladd E. Stevens; Pablo Rubinstein; Mary J. Laughlin

Biology of Blood and Marrow Transplantation | 2006

Peritransplant Use of Ultraviolet-B Irradiation (UV-B) Therapy Is Detrimental to Allogeneic Stem Cell Transplantation Outcome

Meltem Kurt Yuksel; Elma D. Baron; Melissa Camouse; Brenda W. Cooper; Hillard M. Lazarus; Stanton L. Gerson; Mary J. Laughlin; Kevin D. Cooper; Anita C. Gilliam; Pingfu Fu; Seth R. Stevens; Omer N. Koc

Blood | 2009

In Vitro and In Vivo Evidence That Umbilical Cord Blood (UCB)-Derived CD45-/SSEA-4+/OCT-4+/CD133+/CXCR4+/Lin- Very Small Embryonic/Epiblast Like Stem Cells (VSELs) Do Not Contain Clonogenic Hematopoietic Progenitors but Are Highly Enriched in More Primitive Stem Cells - Novel View On Hierarchy of UCB Stem Cell Compartment.

Ewa K. Zuba-Surma; Izabela Klich; Marcin Wysoczynski; Nicholas J Greco; Mary J. Laughlin; Mariusz Z. Ratajczak; Janina Ratajczak

Biology of Blood and Marrow Transplantation | 2009

Preemptive Rituximab Treatment May Reduce the Incidence of Post-Transplant Lymphoproliferative Disorders (PTLD) In Patients with EBV Reactivation after Allogeneic Stem Cell Transplantation

T.L. Kindwall-Keller; Brenda W. Cooper; Mary J. Laughlin; Stanton L. Gerson; Paul M. Barr; S. Erinc; Richard J. Creger; Hillard M. Lazarus

Contemporary Clinical Trials | 2006

Comparison of survival times in a transplant study of hematologic disorders

Pingfu Fu; Mary J. Laughlin; Heping Zhang

Blood | 2005

AF1q Is a Novel Poor Prognostic Marker for Adult Acute Myelogenous Leukemia (AML) Patients with Normal Cytogenetics.

Crawford J. Strunk; Uwe Platzbecker; Christian Thiede; Markus Andreas Schaich; Thomas Illmer; Zizhen Kang; Patrick Leahy; Chunbiao Li; Sunee Reiner; Mary J. Laughlin; Hillard M. Lazarus; Kevin D. Bunting; Stanton L. Gerson; Gerhard Ehninger; William Tse

Biology of Blood and Marrow Transplantation | 2009

Spontaneous Autologous Acute Graft-Versus-Host Disease (GVHD) in Multiple Myeloma (MM) Autologous Stem Cell Transplant (ASCT) Recipients: A Surprisingly High Incidence

Hillard M. Lazarus; S. Subbiah; A. Wakeling; Brenda W. Cooper; S.A. Ataergin; Mary J. Laughlin; Tamila L. Kindwall-Keller; Richard J. Creger; Paul M. Barr; Stanton L. Gerson; K.R. Cooke

Blood | 2009

Proteomic Characterization of Vascular Endothelial Cell-Conditioned Medium Chemo-Attractive to Umbilical Cord Blood Monocytes: Implications for Angiogenesis in Response to Hypoxia.

Graham C. Chapman; Mathew Lesniewski; Chao Yuan; Richard Patrick Weitzel; Nicholas J Greco; Laura R. Fanning; Gordon Preston; Aaron Victor; Philip Paul; Mark Chance; Mary J. Laughlin

Biology of Blood and Marrow Transplantation | 2009

Low Infectious Complication Rates in Hematopoietic Stem Cell Transplantation (HSCT) Recipients: Benefits of A Monthly Monitoring System

T.L. Kindwall-Keller; Brenda W. Cooper; Mary J. Laughlin; Stanton L. Gerson; Paul M. Barr; P. Parker; Michael R. Jacobs; Richard J. Creger; Hillard M. Lazarus

Explore More